Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $85.19B | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $84.97B | Healthcare | Pharmaceuticals | United States | NYSE |
| 3 | $79.70B | Healthcare | Pharmaceutical Retailers | United States | NYSE |
| 4 | $52.68B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 5 | $52.58B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 6 | $51.11B | Healthcare | Pharmaceuticals | United States | NYSE |
| 7 | $41.93B | Healthcare | Pharmaceuticals | United States | NYSE |
| 8 | $33.88B | Healthcare | Pharmaceuticals | United States | NYSE |
| 9 | $31.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $24.93B | Healthcare | Medical Devices | United States | NYSE |
| 11 | $24.42B | Healthcare | Medical Devices | United States | NYSE |
| 12 | $20.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 13 | $19.88B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 14 | $18.85B | Healthcare | Biotechnology | United States | Nasdaq |
| 15 | $18.70B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 16 | $18.17B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 17 | $17.88B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 18 | $15.20B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 19 | $14.26B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 20 | $12.62B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 21 | $11.83B | Healthcare | Biotechnology | United States | Nasdaq |
| 22 | $11.69B | Healthcare | Biotechnology | United States | Nasdaq |
| 23 | $11.57B | Healthcare | Medical Devices | United States | Nasdaq |
| 24 | $11.26B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 25 | $10.97B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 26 | $10.92B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 27 | $10.90B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 28 | $10.62B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 29 | $9.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $8.62B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 31 | $8.61B | Healthcare | Healthcare Providers | United States | NYSE |
| 32 | $7.52B | Healthcare | Healthcare Providers | United States | NYSE |
| 33 | $7.51B | Healthcare | Healthcare Providers | United States | NYSE |
| 34 | $7.21B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 35 | $7.17B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 36 | $6.76B | Healthcare | Biotechnology | United States | Nasdaq |
| 37 | $6.59B | Healthcare | Pharmaceuticals | United States | NYSE |
| 38 | $6.59B | Healthcare | Medical Devices | United States | NYSE |
| 39 | $6.40B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 40 | $6.38B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 41 | $6.35B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 42 | $6.34B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 43 | $6.32B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 44 | $6.17B | Healthcare | Diagnostics & Research | United States | NYSE |
| 45 | $6.06B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 46 | $5.63B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 47 | $5.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 48 | $5.11B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 49 | $4.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 50 | $4.80B | Healthcare | Medical Devices | United States | NYSE |
| 51 | $4.77B | Healthcare | Medical Devices | United States | NYSE |
| 52 | $4.66B | Healthcare | Healthcare Providers | United States | NYSE |
| 53 | $4.23B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 54 | $4.23B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 55 | $3.69B | Healthcare | Biotechnology | United States | Nasdaq |
| 56 | $3.49B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 57 | $3.44B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 58 | $3.15B | Healthcare | Pharmaceuticals | United States | NYSE |
| 59 | $3.10B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 60 | $3.08B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 61 | $2.99B | Healthcare | Medical Devices | United States | NYSE |
| 62 | $2.99B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 63 | $2.96B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 64 | $2.95B | Healthcare | Medical Devices | United States | NYSE |
| 65 | $2.90B | Healthcare | Medical Devices | United States | NYSE |
| 66 | $2.84B | Healthcare | Diagnostics & Research | United States | NYSE |
| 67 | $2.84B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 68 | $2.80B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 69 | $2.76B | Healthcare | Biotechnology | United States | Nasdaq |
| 70 | $2.62B | Healthcare | Medical Devices | United States | Nasdaq |
| 71 | $2.61B | Healthcare | Biotechnology | United States | Nasdaq |
| 72 | $2.60B | Healthcare | Healthcare Providers | United States | NYSE |
| 73 | $2.54B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 74 | $2.52B | Healthcare | Pharmaceuticals | United States | NYSE |
| 75 | $2.44B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 76 | $2.40B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 77 | $2.11B | Healthcare | Biotechnology | United States | Nasdaq |
| 78 | $2.11B | Healthcare | Biotechnology | United States | Nasdaq |
| 79 | $2.05B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 80 | $1.98B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 81 | $1.92B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 82 | $1.92B | Healthcare | Pharmaceuticals | United States | NYSE |
| 83 | $1.84B | Healthcare | Biotechnology | United States | Nasdaq |
| 84 | $1.82B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 85 | $1.81B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 86 | $1.75B | Healthcare | Biotechnology | United States | Nasdaq |
| 87 | $1.72B | Healthcare | Medical Devices | United States | NYSE |
| 88 | $1.68B | Healthcare | Medical Devices | United States | Nasdaq |
| 89 | $1.63B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 90 | $1.62B | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 91 | $1.61B | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 92 | $1.53B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 93 | $1.53B | Healthcare | Medical Devices | United States | NYSE |
| 94 | $1.51B | Healthcare | Biotechnology | United States | Nasdaq |
| 95 | $1.48B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 96 | $1.48B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 97 | $1.42B | Healthcare | Medical Devices | United States | Nasdaq |
| 98 | $1.40B | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 99 | $1.38B | Healthcare | Healthcare Providers | United States | Nasdaq |
| 100 | $1.36B | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 723 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.